INTEGRILIN Side Effects

6287658-X | Ecchymosis, Skin Discolouration
on Oct 08, 2008 Male patient from UNITED STATES , 72 years of age, was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: ecchymosis, skin discolouration. Integrilin dosage: .

6280127-2 | Compartment Syndrome, Gastrointestinal Haemorrhage, Renal Failure
Patient was taking Integrilin (View Usage). Patient had the following side effects: compartment syndrome, gastrointestinal haemorrhage, renal failure on Jul 15, 2009 from GERMANY Additional patient health information: Male patient , weighting 202.8 lb, was diagnosed with acute coronary syndrome and. Integrilin dosage: . During the same period patient was treated with ASA LOW DOSE (At Least 300 Mg D1; 75-100 Mg From D2 To D30) (View Asa Low Dose Review and Asa Low Dose Label ), CLOPIDOGREL (600 Mg Ld D1 Followed By 150 Mg From D2 To D7; 75 Mg From D8 To 30) (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ), KONAKION (View Konakion Review and Konakion Label ).

6274771-6 | Cardio-respiratory Arrest, Convulsion, Haemodynamic Instability, Haemothorax, Post Procedural Haematoma, Post Procedural Haemorrhage, Retroperitoneal Haemorrhage, Unresponsive To Stimuli
Adverse event was reported on Jul 14, 2009 by a Female patient taking Integrilin (View Usage) (Dosage: Once; Indrp) was diagnosed with coronary artery disease (What is coronary artery disease?), stent placement and. Location: UNITED STATES , 56 years of age, After Integrilin was administered, patient had the following side effects: cardio-respiratory arrest, convulsion, haemodynamic instability, haemothorax, post procedural haematoma, post procedural haemorrhage, retroperitoneal haemorrhage, unresponsive to stimuli. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ANGIOMAX (View Angiomax Review and Angiomax Label ), PLAVIX (30 Mg;po) (View Plavix Review and Plavix Label ).

6249176-4 | Aspiration, Haemorrhage Intracranial, Unresponsive To Stimuli, Vomiting
on Jun 24, 2009 Male patient from UNITED STATES , weighting 269.0 lb, was diagnosed with biopsy kidney and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, haemorrhage intracranial, unresponsive to stimuli, vomiting. Integrilin dosage: 180mcg/kg Bolus - 1 Mcg/kg/min Iv Drip. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).


6248448-7 | Renal Failure
on Jun 19, 2009 Male patient from UNITED STATES , 50 years of age, weighting 220.5 lb, was treated with Integrilin (View Usage). Patient had the following side effects: renal failure. Integrilin dosage: Inb. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6210352-8 | Acute Coronary Syndrome, Bradycardia, Deep Vein Thrombosis, Diastolic Dysfunction, Ejection Fraction Decreased, Electromechanical Dissociation, Pulmonary Hypertension, Thrombocytopenia, Thrombophlebitis Superficial
Patient was taking Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: acute coronary syndrome, bradycardia, deep vein thrombosis (What is deep vein thrombosis?), diastolic dysfunction, ejection fraction decreased, electromechanical dissociation, pulmonary hypertension (What is pulmonary hypertension?), thrombocytopenia, thrombophlebitis superficial on May 18, 2009 from UNITED STATES Additional patient health information: Male patient , 65 years of age, . Integrilin dosage: . During the same period patient was treated with UNFRACTIONATED HEPARIN (View Unfractionated Heparin Review and Unfractionated Heparin Label ). Patient was hospitalized.

6204936-0 | Artery Dissection, Cardiac Disorder, Cardiac Tamponade, Cell-mediated Cytotoxicity, Gastrointestinal Haemorrhage, Haemorrhagic Diathesis, Megakaryocytes Decreased, Oliguria, Pericardial Haemorrhage
Adverse event was reported on May 15, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: 20 Mg; Once; Iv) was diagnosed with coronary angioplasty and. Location: GERMANY , 67 years of age, Patient experienced the following unwanted or unexpected effects: artery dissection, cardiac disorder, cardiac tamponade, cell-mediated cytotoxicity, gastrointestinal haemorrhage, haemorrhagic diathesis, megakaryocytes decreased, oliguria, pericardial haemorrhage. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6204343-0 | Arteriospasm Coronary, Blood Pressure Decreased, Feeling Hot, Malaise, Presyncope
on May 13, 2009 Female patient from AUSTRALIA , 51 years of age, weighting 242.5 lb, was diagnosed with myocardial infarction and was treated with Integrilin (View Usage). Patient had the following side effects: arteriospasm coronary, blood pressure decreased, feeling hot, malaise, presyncope. Integrilin dosage: 10.2 Ml; Once; Inbo; Once; Iv;. During the same period patient was treated with GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6189803-3 | Arterial Haemorrhage, Gastrointestinal Haemorrhage, Thrombocytopenia
on May 12, 2009 Female patient from UNITED STATES , 72 years of age, weighting 73.00 lb, was diagnosed with percutaneous coronary intervention and was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: arterial haemorrhage, gastrointestinal haemorrhage, thrombocytopenia. Integrilin dosage: 180 Mcg Kg Q 10 Min X 2 Iv Bolus. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ), UNFRACTIONATED HEPARIN (View Unfractionated Heparin Review and Unfractionated Heparin Label ). Patient was hospitalized.

6184143-0 | Gingival Bleeding, Platelet Count Decreased
Patient was taking Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: gingival bleeding, platelet count decreased on May 06, 2009 from UNITED STATES Additional patient health information: Male patient , 34 years of age, weighting 142.0 lb, was diagnosed with acute myocardial infarction and. Integrilin dosage: .

6146417-9 | Acute Respiratory Failure, Pulmonary Alveolar Haemorrhage, Pulmonary Embolism
Adverse event was reported on Mar 23, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: Inbo) . Location: UNITED STATES , 62 years of age, Patient had the following side effects: acute respiratory failure, pulmonary alveolar haemorrhage, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6146410-6 | Pulmonary Alveolar Haemorrhage, Pulmonary Embolism
on Mar 23, 2009 Male patient from UNITED STATES , 63 years of age, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: pulmonary alveolar haemorrhage, pulmonary embolism (What is pulmonary embolism?). Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6146260-0 | Pulmonary Alveolar Haemorrhage
on Mar 23, 2009 Male patient from UNITED STATES , 64 years of age, was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary alveolar haemorrhage. Integrilin dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ).

6137466-5 | Coronary Artery Thrombosis
Patient was taking Integrilin (View Usage). Patient had the following side effects: coronary artery thrombosis on Mar 18, 2009 from AUSTRALIA Additional patient health information: Female patient , 75 years of age, weighting 136.7 lb, was diagnosed with thrombosis and. Integrilin dosage: 5.6 Ml;inbo;inbo ; Im ; Inbo. Patient was hospitalized.

6132706-0 | Platelet Count Decreased
Adverse event was reported on Mar 24, 2009 by a Female patient taking Integrilin (View Usage) (Dosage: 5ml Bolus X 2 9 Min Apart Iv) was diagnosed with catheterisation cardiac and. Location: UNITED STATES , 60 years of age, weighting 125.7 lb, After Integrilin was administered, patient had the following side effects: platelet count decreased. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6124538-4 | Post Procedural Complication, Thrombocytopenia
on Mar 17, 2009 Male patient from UNITED STATES , 68 years of age, weighting 230.0 lb, was diagnosed with stent placement and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural complication, thrombocytopenia. Integrilin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6106538-3 | Pulmonary Alveolar Haemorrhage, Pulmonary Embolism
on Feb 20, 2009 Male patient from UNITED STATES , 63 years of age, was treated with Integrilin (View Usage). Patient had the following side effects: pulmonary alveolar haemorrhage, pulmonary embolism (What is pulmonary embolism?). Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6106520-6 | Acute Myocardial Infarction, Pulmonary Alveolar Haemorrhage, Pulmonary Embolism
Patient was taking Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: acute myocardial infarction, pulmonary alveolar haemorrhage, pulmonary embolism (What is pulmonary embolism?) on Feb 20, 2009 from UNITED STATES Additional patient health information: Male patient , 64 years of age, . Integrilin dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ).

6104658-0 | Acute Respiratory Failure, Pulmonary Alveolar Haemorrhage, Pulmonary Embolism
Adverse event was reported on Feb 20, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: Inbo; Iv) . Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, pulmonary alveolar haemorrhage, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6097851-7 | Bradycardia, Hypotension, Rash Erythematous
on Feb 16, 2009 Male patient from AUSTRALIA , 69 years of age, was treated with Integrilin (View Usage). Patient had the following side effects: bradycardia, hypotension, rash erythematous. Integrilin dosage: 12 Ml; Qh; Iv.

6094393-X | Activated Partial Thromboplastin Time Prolonged, Blood Fibrinogen Increased, Cerebrovascular Accident, Haemoglobin Decreased, Hepatic Failure, International Normalised Ratio Decreased, Multi-organ Failure, Renal Failure
on Feb 16, 2009 Male patient from AUSTRALIA , 65 years of age, weighting 187.4 lb, was diagnosed with haemorrhage and was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, cerebrovascular accident, haemoglobin decreased, hepatic failure, international normalised ratio decreased, multi-organ failure, renal failure. Integrilin dosage: . During the same period patient was treated with NOVO SEVEN (EPTACOG ALFA (ACTIVATED)) (8.4 Mg; Once; Iv) (View Novo Seven (eptacog Alfa (activated)) Review and Novo Seven (eptacog Alfa (activated)) Label ), TRASYLOL (View Trasylol Review and Trasylol Label ), ALBUMEX 20 (View Albumex 20 Review and Albumex 20 Label ), HEPARIN SODIUM INJECTION (View Heparin Sodium Injection Review and Heparin Sodium Injection Label ), LIGNOCAINE (View Lignocaine Review and Lignocaine Label ), PROTAMINE SULFATE (View Protamine Sulfate Review and Protamine Sulfate Label ).

6088168-5 | Arterial Thrombosis, Neoplasm Malignant
Patient was taking Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: arterial thrombosis, neoplasm malignant on Feb 06, 2009 from AUSTRALIA Additional patient health information: Female patient , 75 years of age, weighting 136.7 lb, was diagnosed with thrombosis and. Integrilin dosage: 5.6 Ml Inbo Iv; Unk Im; Inbo. Patient was hospitalized.

6085246-1 | Arteriospasm Coronary, Blood Pressure Decreased, Electrocardiogram Change, Feeling Hot
Adverse event was reported on Feb 03, 2009 by a Female patient taking Integrilin (View Usage) (Dosage: 10.2 Ml Once; Inbo) was diagnosed with myocardial infarction and. Location: AUSTRALIA , 51 years of age, weighting 242.5 lb, Patient had the following side effects: arteriospasm coronary, blood pressure decreased, electrocardiogram change, feeling hot. During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

6074911-8 | Post Procedural Complication, Retroperitoneal Haemorrhage, Thrombosis
on Jan 30, 2009 Female patient from UNITED STATES , 90 years of age, weighting 142.0 lb, was diagnosed with acute myocardial infarction and was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: post procedural complication, retroperitoneal haemorrhage, thrombosis. Integrilin dosage: 5.6 Ml Once; Iv, 10 Ml, Qh; Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), PLAVIX (75 Mg, Po) (View Plavix Review and Plavix Label ), MECLIZINE (View Meclizine Review and Meclizine Label ), ALLEGRA D 24 HOUR (View Allegra D 24 Hour Review and Allegra D 24 Hour Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

6063200-3 | Haemorrhagic Stroke
on Jan 26, 2009 Male patient from ISRAEL , 46 years of age, was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhagic stroke. Integrilin dosage: .

6054958-8 | Artery Dissection, Blood Immunoglobulin G Abnormal, Cardiac Procedure Complication, Cardiac Tamponade, Gastrointestinal Haemorrhage, Left Ventricular Failure, Megakaryocytes Decreased, Pericardial Haemorrhage, Pulmonary Oedema
Patient was taking Integrilin (View Usage). Patient had the following side effects: artery dissection, blood immunoglobulin g abnormal, cardiac procedure complication, cardiac tamponade, gastrointestinal haemorrhage, left ventricular failure, megakaryocytes decreased, pericardial haemorrhage, pulmonary oedema on Jan 09, 2009 from GERMANY Additional patient health information: Male patient , 67 years of age, was diagnosed with coronary angioplasty and. Integrilin dosage: 20 Mg; Once; Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6015395-5 | Chest Pain, Extradural Haematoma, Post Procedural Complication, Quadriplegia, Spinal Cord Compression
Adverse event was reported on Dec 04, 2008 by a Male patient taking Integrilin (View Usage) (Dosage: Iv) was diagnosed with coronary angioplasty and. Location: FRANCE , 68 years of age, After Integrilin was administered, patient had the following side effects: chest pain (What is chest pain?), extradural haematoma, post procedural complication, quadriplegia, spinal cord compression. During the same period patient was treated with LOVENOX (Iv) (View Lovenox Review and Lovenox Label ), ASPIRIN (75 Mg Qd Po) (View Aspirin Review and Aspirin Label ), PLAVIX (75 Mg Qd Po) (View Plavix Review and Plavix Label ).

6015356-6 | Anti-platelet Antibody Positive, Apoptosis, Cardiac Tamponade, Coronary Artery Dissection, Gastrointestinal Haemorrhage, Haemorrhagic Diathesis, Left Ventricular Failure, Megakaryocytes Decreased, Oliguria
on Dec 09, 2008 Male patient from GERMANY , 67 years of age, was diagnosed with coronary angioplasty and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: anti-platelet antibody positive, apoptosis, cardiac tamponade, coronary artery dissection, gastrointestinal haemorrhage, haemorrhagic diathesis, left ventricular failure, megakaryocytes decreased, oliguria. Integrilin dosage: 20 Mg Once Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6002192-X | Postoperative Thrombosis, Retroperitoneal Haemorrhage
on Dec 08, 2008 Female patient from UNITED STATES , 90 years of age, weighting 142.0 lb, was diagnosed with acute myocardial infarction and was treated with Integrilin (View Usage). Patient had the following side effects: postoperative thrombosis, retroperitoneal haemorrhage. Integrilin dosage: 5.6 Ml; Once; Iv, 10 Ml; Qh; Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), PLAVIX (View Plavix Review and Plavix Label ), MECLIZINE (CON.) (View Meclizine (con.) Review and Meclizine (con.) Label ), ALLEGRA D (CON.) (View Allegra-d (con.) Review and Allegra-d (con.) Label ), ZOLOFT (CON.) (View Zoloft (con.) Review and Zoloft (con.) Label ), AZITHROMYCIN (CON.) (View Azithromycin (con.) Review and Azithromycin (con.) Label ). Patient was hospitalized.

5990031-2 | Post Procedural Haemorrhage, Postoperative Thrombosis, Retroperitoneal Haemorrhage
Patient was taking Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: post procedural haemorrhage, postoperative thrombosis, retroperitoneal haemorrhage on Dec 03, 2008 from UNITED STATES Additional patient health information: Female patient , 79 years of age, weighting 142.0 lb, was diagnosed with acute myocardial infarction and. Integrilin dosage: 5.6 Ml; Once; Iv; 10 Ml; Qh; Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5982001-5 | Acute Myocardial Infarction, Confusional State, Disseminated Intravascular Coagulation, Electromechanical Dissociation, Hypotension, Platelet Count Decreased, Post Procedural Haematoma, Prothrombin Time Prolonged, Thrombosis
Adverse event was reported on Nov 24, 2008 by a Male patient taking Integrilin (View Usage) (Dosage: Inbo) . Location: UNITED STATES , 60 years of age, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, confusional state, disseminated intravascular coagulation, electromechanical dissociation, hypotension, platelet count decreased, post procedural haematoma, prothrombin time prolonged, thrombosis. During the same period patient was treated with PLAVIX (75 Mg; Po) (View Plavix Review and Plavix Label ), ANGIOMAX (Iv) (View Angiomax Review and Angiomax Label ), ZOCOR (View Zocor Review and Zocor Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5944526-8 | Chills, Pyrexia, Thrombocytopenia
on Oct 27, 2008 Male patient from AUSTRALIA , 69 years of age, was treated with Integrilin (View Usage). Patient had the following side effects: chills, pyrexia, thrombocytopenia. Integrilin dosage: 1 Df; Once; Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), TRITACE (View Tritace Review and Tritace Label ), ZYLOPRIM (View Zyloprim Review and Zyloprim Label ). Patient was hospitalized.

5924731-7 | Gait Disturbance, Walking Aid User
on Oct 08, 2008 Female patient from UNITED STATES , 75 years of age, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: gait disturbance, walking aid user. Integrilin dosage: .

5904213-9 | Brain Oedema, Cerebral Haematoma, Headache, Nausea, Post Procedural Haematoma
Patient was taking Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, cerebral haematoma, headache (What is headache?), nausea (What is nausea?), post procedural haematoma on Sep 30, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 220.5 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Integrilin dosage: . Patient was hospitalized and became disabled.

5816607-0 | Retroperitoneal Haemorrhage
Adverse event was reported on Feb 29, 2008 by a Female patient taking Integrilin (View Usage) (Dosage: 2 ; Once ; 18 Ml;qh) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: retroperitoneal haemorrhage. During the same period patient was treated with HEPARIN (6000) (View Heparin Review and Heparin Label ), PLAVIX (600 Mg) (View Plavix Review and Plavix Label ).

5816606-9 | Cerebral Infarction, Subarachnoid Haemorrhage
on Mar 13, 2008 Female patient from UNITED STATES , 66 years of age, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: cerebral infarction, subarachnoid haemorrhage. Integrilin dosage: Inbo ; Indrp. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5816605-7 | Thrombocytopenia
on Mar 12, 2008 Male patient from UNITED STATES , 53 years of age, was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Integrilin dosage: 180 Mcg/kg;once;inbo ; 180 Mcg/kg;once;inbo ; 2 Mcg/kg;iv. During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

5816604-5 | Thrombocytopenia
Patient was taking Integrilin (View Usage). Patient had the following side effects: thrombocytopenia on Mar 11, 2008 from UNITED STATES Additional patient health information: Female patient , 53 years of age, was diagnosed with angina unstable, catheter placement and. Integrilin dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5816601-X | Retroperitoneal Haemorrhage
Adverse event was reported on Mar 31, 2008 by a Female patient taking Integrilin (View Usage) (Dosage: ) . Location: UNITED STATES , 56 years of age, After Integrilin was administered, patient had the following side effects: retroperitoneal haemorrhage. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5816598-2 | Haemorrhage Intracranial
on May 15, 2008 Male patient from UNITED STATES , 76 years of age, weighting 180.0 lb, was diagnosed with coronary angioplasty and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial. Integrilin dosage: 7.3 Ml;once;inbo ; 7.3 Ml;once;inbo ; 13 Ml;qh;indrp. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5816577-5 | Cerebral Haemorrhage
on Nov 08, 2007 Male patient from UNITED STATES , 80 years of age, was diagnosed with myocardial infarction and was treated with Integrilin (View Usage). Patient had the following side effects: cerebral haemorrhage. Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), TENECTEPLASE (View Tenecteplase Review and Tenecteplase Label ).

5816576-3 | Gastrointestinal Haemorrhage
Patient was taking Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: gastrointestinal haemorrhage on Nov 01, 2007 from UNITED STATES Additional patient health information: Female patient , 85 years of age, . Integrilin dosage: .

5816565-9 | Cerebrovascular Accident
Adverse event was reported on Jan 29, 2008 by a Female patient taking Integrilin (View Usage) (Dosage: ) . Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident.

5816564-7 | Haemorrhage Intracranial, Thrombocytopenia
on Jan 23, 2008 Male patient from UNITED STATES , 54 years of age, weighting 213.8 lb, was diagnosed with acute coronary syndrome and was treated with Integrilin (View Usage). Patient had the following side effects: haemorrhage intracranial, thrombocytopenia. Integrilin dosage: Iv. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AVAPRO (View Avapro Review and Avapro Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), LASIX (View Lasix Review and Lasix Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), IMDUR (View Imdur Review and Imdur Label ).

5808278-4 | Artery Dissection, Bleeding Time Prolonged, Brain Herniation, Breath Sounds Abnormal, Cardiac Arrest, Cardiovascular Disorder, Cerebral Haematoma, Convulsion, Haemorrhage
on Jun 30, 2008 Male patient from UNITED STATES , 51 years of age, weighting 245.0 lb, was diagnosed with acute myocardial infarction and was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: artery dissection, bleeding time prolonged, brain herniation, breath sounds abnormal, cardiac arrest (What is cardiac arrest?), cardiovascular disorder, cerebral haematoma, convulsion, haemorrhage. Integrilin dosage: Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

5794910-0 | Atrioventricular Block Complete, Chest Pain, Electrocardiogram St Segment Depression, Electrocardiogram St Segment Elevation, Hypoxia, Procedural Complication, Productive Cough, Pulmonary Alveolar Haemorrhage
Patient was taking Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, chest pain (What is chest pain?), electrocardiogram st segment depression, electrocardiogram st segment elevation, hypoxia, procedural complication, productive cough, pulmonary alveolar haemorrhage on Jun 27, 2008 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 159.8 lb, was diagnosed with percutaneous coronary intervention, acute myocardial infarction and. Integrilin dosage: 12.4mg X 2 Doses Iv Bolus.

5776708-2 | Anaemia, Small Intestinal Haemorrhage
Adverse event was reported on May 29, 2008 by a Male patient taking Integrilin (View Usage) (Dosage: Iv) was diagnosed with arteriogram coronary and. Location: FRANCE , 77 years of age, Patient had the following side effects: anaemia, small intestinal haemorrhage. During the same period patient was treated with CLOPIDOGREL BISULFATE (75 Mg;qd;po) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), LYSINE ASPIRIN (ACETYLSALICYLATE LYSINE) (75 Mg;qd;po) (View Lysine Aspirin (acetylsalicylate Lysine) Review and Lysine Aspirin (acetylsalicylate Lysine) Label ), HEPARIN (26000 Iu; Iv, 36000 Iu; Iv) (View Heparin Review and Heparin Label ). Patient was hospitalized.

5764805-7 | Acute Myocardial Infarction, Cardio-respiratory Arrest, Coronary Artery Stenosis, Thrombocytopenia, Thrombosis, Ventricular Fibrillation, Ventricular Tachycardia
on May 29, 2008 Male patient from UNITED STATES , 77 years of age, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: acute myocardial infarction, cardio-respiratory arrest, coronary artery stenosis, thrombocytopenia, thrombosis, ventricular fibrillation, ventricular tachycardia. Integrilin dosage: . During the same period patient was treated with ASPIRIN (325 Mg; Qd; Po) (View Aspirin Review and Aspirin Label ), PLAVIX (75 Mg; Po) (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ZOCOR (View Zocor Review and Zocor Label ).

5747039-1 | Cardiac Tamponade, Device Leakage, Medical Device Complication, Pericardial Haemorrhage
on May 14, 2008 Male patient from UNITED STATES , 57 years of age, was diagnosed with acute coronary syndrome and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac tamponade, device leakage, medical device complication, pericardial haemorrhage. Integrilin dosage: Iv. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

5747033-0 | Chest Pain, Myocardial Infarction, Thrombocytopenia, Thrombosis
Patient was taking Integrilin (View Usage). Patient had the following side effects: chest pain (What is chest pain?), myocardial infarction, thrombocytopenia, thrombosis on May 14, 2008 from UNITED STATES Additional patient health information: Male patient , 77 years of age, . Integrilin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ).